Loading
institutionsInstitution
Seoul St. Mary's Hospital
Korea's largest blood cancer centre, where much of the country's haematopoietic transplant and leukaemia expertise was built.
Also called: Catholic University of Korea Seoul St. Mary's Hospital서울성모병원
Overview
Seoul St. Mary's Hospital, the flagship of the Catholic Medical Center, opened its current campus in 2009 and houses the Catholic Hematology Hospital, Korea's highest-volume haematopoietic stem cell transplant programme and a national leader in acute leukaemia, myeloma and chronic myeloid leukaemia research (including early Asian trials of tyrosine kinase inhibitors led by Dong-Wook Kim). The hospital also runs a comprehensive cancer hospital with breast, thyroid, colorectal and lung programmes, robotic surgery, and a proton therapy project, and it is a frequent Korean site for haematology and solid tumour registration trials.
Location
Seoul, KR
Type
hospital · Catholic University of Korea
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#317 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to The Catholic University of Korea Seoul St. Mary's Hospital, including child institutions. 448 works · 2,611 citations · 74% open access · 13% clinical trials · 2% reviews.
Oncology works per year
912022
1012023
832024
982025
752026
Most works
- Yoon Suk Lee26 works
- Seok‐Goo Cho24 works
- Tae Ho Hong21 works
- Myung Ah Lee19 works
- Kabsoo Shin18 works
- Se Jun Park17 works
- In Kyu Lee16 works
- Sung Hak Lee15 works
- Bong‐Hyeon Kye14 works
- Don A. Stevens13 works
Most cited
- Catholic Hematology Hospital
- Haematopoietic stem cell transplant
- Chronic myeloid leukaemia
- Robotic surgery
Similar pages
- PersonStephen J. Forman
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- CompanyImugene
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
- CompanyAllotera Therapeutics (formerly Wugen)
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- CompanyPoseida Therapeutics
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Multiple myeloma, Diffuse large B-cell lymphoma.
- TechnologyNK cell therapy and CAR-NK
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute myeloid leukaemia, Diffuse large B-cell lymphoma.
- TargetCD7
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- IdeaPlan the second CAR-T target before the first one is lost
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Multiple myeloma.
- InstitutionChristian Medical College, Vellore
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.